The potentiation of the neuromuscular blocking activity of hexafluorenium and d-tubocurarine by volatile anaesthetics.
D000777:Anesthetics / Q000009:adverse effects / Q000097:blood / Q000494:pharmacology*; D000818:Animals; D002415:Cats; D004357:Drug Synergism; D004987:Ethers / Q000097:blood / Q000494:pharmacology*; D005260:Female; D005449:Fluorenes / Q000097:blood / Q000494:pharmacology*; D006221:Halothane / Q000097:blood / Q000494:pharmacology*; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009469:Neuromuscular Junction / Q000187:drug effects*; D010243:Paralysis / Q000139:chemically induced; D000644:Quaternary Ammonium Compounds / Q000097:blood / Q000494:pharmacology; D014403:Tubocurarine / Q000097:blood / Q000494:pharmacology*
D000777:Anesthetics; D004987:Ethers; D005449:Fluorenes; D000644:Quaternary Ammonium Compounds; D006221:Halothane; D014403:Tubocurarine